Last reviewed · How we verify
Hearing Aid with NR_4
At a glance
| Generic name | Hearing Aid with NR_4 |
|---|---|
| Sponsor | Sonova AG |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Effect of Mild-gain Amplification on Tinnitus Perception in Normal Hearing Adults (NA)
- Assessment of Novel Sound Changing Principles in Hearing Instruments to Determine Their Application - 2019_20 (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hearing Aid with NR_4 CI brief — competitive landscape report
- Hearing Aid with NR_4 updates RSS · CI watch RSS
- Sonova AG portfolio CI